Advertisement

Topics

Grünenthal GmbH Company Profile

13:41 EST 15th December 2018 | BioPortfolio

Nil

Location

Aachen
D-52099
Germany

Contact

Phone: 49 241 569 - 1522
Email: info@grunenthal.com


News Articles [179 Associated News Articles listed on BioPortfolio]

Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US

Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercia...

AstraZeneca Divests Two Drugs to Grünenthal in $90 Million Deal

Privately-held Grunenthal GmbH will pay AstraZeneca $700 million for the prescription medicine rights to acid-reflux medicine Nexium. The deal with AstraZeneca represents the largest investment in Gr...

Grünenthal buys certain rights to AZ’s Nexium and Vimovo for $922m

AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million. The move represents the biggest single investment to date for t...

Grünenthal to buy AstraZeneca’s European rights to two drugs for $922m

For Nexium, which is used in the treatment of gastroesophageal reflux disease, ulcers, and Zollinger-Ellison syndrome, Grünenthal will be acquiring the prescription medicine rights in Europe, which w...

AstraZeneca signs $922m licensing deal with Grünenthal

AstraZeneca has announced plans to sell certain prescription medicine rights for Nexium and Vimovo to German pharmaceutical company Grünenthal Group...Read More... The post AstraZeneca signs $922m li...

Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M

Grünenthal has agreed to acquire AstraZeneca's European rights to Nexium (esomeprazole) and the pharma giant’s rights to Vimovo® (naproxen/esomeprazole) worldwide except the U.S. and J...

AstraZeneca Sells Drug Rights to Grünenthal

AstraZeneca is selling certain rights to Nexium and Vimovo to German drugmaker Grünenthal, having decided the drugs falls outside its main therapy areas of oncology, cardiovascular, renal & metab...

Grünenthal Snaps Up Averitas Pharma for Undisclosed Sum to Extend Presence in the U.S.

Two weeks after acquiring two drugs from AstraZeneca in a $700 million deal, Germany-based Grünenthal flexed its M&A muscle again to acquire Averitas Pharma to extend its commercial footprint in the ...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

Evaluation of Physicochemical Properties of New Calcium Silicate-Based Sealer.

This study aimed to evaluate the physicochemical properties of a calcium silicate-based sealer (Sealer Plus BC; MK Life, Porto Alegre, Brazil) compared with an epoxy-resin sealer (AH Plus; Dentsply De...

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [536 Associated Companies listed on BioPortfolio]

Grünenthal Group

The Grünenthal Group is an independent, family-owned company, headquartered in Aachen, Germany. It is present in 32 countries with affiliates in Europe, Latin America and the U...

Grünenthal

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...

Grünenthal GmbH

Nil

Gr?nenthal

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "Grünenthal GmbH" on BioPortfolio

We have published hundreds of Grünenthal GmbH news stories on BioPortfolio along with dozens of Grünenthal GmbH Clinical Trials and PubMed Articles about Grünenthal GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal GmbH Companies in our database. You can also find out about relevant Grünenthal GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record